Authors
Karan D Joshi, Dharmraj Pathak, Abhishek Dave, Omkumar Prajapati, Mahesh A Barmade, Mange Ram Yadav, Prashant R Murumkar
Published in
Mini reviews in medicinal chemistry. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
Alzheimer's disease (AD) is a multifaceted neurodegenerative disease involving many pathophysiological factors in its genesis. While its complex etiology poses significant therapeutic challenges, it also presents opportunities to develop novel drugs that modulate specific biological targets involved in its pathogenesis. Pyrazole is a privileged scaffold present in various molecules with the potential to ameliorate multiple diseases and disorders. Several pyrazole -containing molecules have cleared clinical trials and are currently available on the market, highlighting the pyrazole ring as a promising scaffold for drug design. Researchers have designed, synthesized, and evaluated an array of biologically active pyrazole derivatives, targeting different pathways in AD, reporting promising lead molecules with potent activities. This review comprehensively covers the literature on pyrazole-containing compounds as Anti-AD agents capable of targeting key pathophysiological hallmarks, such as cholinergic esterase enzymes (AChE/BuChE inhibitors), amyloid (Aβ40-42 aggregation inhibitors), tau protein (GSK3β inhibitors), biometals (metal chelators, antioxidants, and ROS scavengers), and certain newer targets like MAO (MAO-A/B inhibitors) and PDE (PDE 1-10 inhibitors).
PMID:
43023504
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0